208 related articles for article (PubMed ID: 26965653)
1. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice.
Souza LC; Jesse CR; Antunes MS; Ruff JR; de Oliveira Espinosa D; Gomes NS; Donato F; Giacomeli R; Boeira SP
Brain Behav Immun; 2016 Aug; 56():363-77. PubMed ID: 26965653
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
O'Connor JC; Lawson MA; André C; Moreau M; Lestage J; Castanon N; Kelley KW; Dantzer R
Mol Psychiatry; 2009 May; 14(5):511-22. PubMed ID: 18195714
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory.
Heisler JM; O'Connor JC
Brain Behav Immun; 2015 Nov; 50():115-124. PubMed ID: 26130057
[TBL] [Abstract][Full Text] [Related]
6. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures.
Fu X; Zunich SM; O'Connor JC; Kavelaars A; Dantzer R; Kelley KW
J Neuroinflammation; 2010 Aug; 7():43. PubMed ID: 20678226
[TBL] [Abstract][Full Text] [Related]
7. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression.
Dobos N; de Vries EF; Kema IP; Patas K; Prins M; Nijholt IM; Dierckx RA; Korf J; den Boer JA; Luiten PG; Eisel UL
J Alzheimers Dis; 2012; 28(4):905-15. PubMed ID: 22112548
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of pranlukast on Aβ₁₋₄₂-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1.
Tang SS; Ji MJ; Chen L; Hu M; Long Y; Li YQ; Miao MX; Li JC; Li N; Ji H; Chen XJ; Hong H
Int J Neuropsychopharmacol; 2014 Apr; 17(4):581-92. PubMed ID: 24229499
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice.
Corona AW; Norden DM; Skendelas JP; Huang Y; O'Connor JC; Lawson M; Dantzer R; Kelley KW; Godbout JP
Brain Behav Immun; 2013 Jul; 31():134-42. PubMed ID: 22926082
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease.
Yamada A; Akimoto H; Kagawa S; Guillemin GJ; Takikawa O
J Neurochem; 2009 Aug; 110(3):791-800. PubMed ID: 19457071
[TBL] [Abstract][Full Text] [Related]
11. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
12. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
Criado G; Simelyte E; Inglis JJ; Essex D; Williams RO
Arthritis Rheum; 2009 May; 60(5):1342-51. PubMed ID: 19404944
[TBL] [Abstract][Full Text] [Related]
14. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
[TBL] [Abstract][Full Text] [Related]
15. Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?
Colaianna M; Tucci P; Zotti M; Morgese MG; Schiavone S; Govoni S; Cuomo V; Trabace L
Br J Pharmacol; 2010 Apr; 159(8):1704-15. PubMed ID: 20218978
[TBL] [Abstract][Full Text] [Related]
16. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy.
Xie W; Cai L; Yu Y; Gao L; Xiao L; He Q; Ren Z; Liu Y
J Neuroinflammation; 2014 Mar; 11():41. PubMed ID: 24594021
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge.
Salazar A; Gonzalez-Rivera BL; Redus L; Parrott JM; O'Connor JC
Horm Behav; 2012 Aug; 62(3):202-9. PubMed ID: 22504306
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice.
Zhang C; Cheng Y; Wang H; Wang C; Wilson SP; Xu J; Zhang HT
J Alzheimers Dis; 2014; 38(2):269-80. PubMed ID: 23948935
[TBL] [Abstract][Full Text] [Related]
19. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
Meunier J; Villard V; Givalois L; Maurice T
Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
[TBL] [Abstract][Full Text] [Related]
20. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
